Immuron Ltd SEC filings IMRN

Immuron Ltd has 427 filings in SEC EDGAR's recent list, going back to Dec 21, 2016. Its latest annual report, Form 20-F, was filed on Sep 24, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on June 30.

Immuron Ltd SEC filings
Form Description Filed Period
424B5 Prospectus supplement Oct 23, 2026 —
424B5 Prospectus supplement Oct 3, 2025 —
F-3 Shelf registration (foreign issuer) Jul 3, 2024 —
424B5 Prospectus supplement Jul 23, 2020 —
424B5 Prospectus supplement Jul 17, 2019 —
424B5 Prospectus supplement Jul 16, 2019 —
424B5 Prospectus supplement May 28, 2019 —
424B5 Prospectus supplement May 23, 2019 —
F-3 Shelf registration (foreign issuer) Apr 8, 2019 —
F-3 Shelf registration (foreign issuer) Apr 1, 2019 —
POS AM Filing Jan 14, 2019 —
424B3 Prospectus Mar 19, 2018 —
FWP Free writing prospectus Mar 13, 2018 —
FWP Free writing prospectus Mar 12, 2018 —
424B3 Prospectus Jan 18, 2018 —
FWP Free writing prospectus Jan 11, 2018 —
424B3 Prospectus Nov 2, 2017 —
424B3 Prospectus Aug 3, 2017 —
424B4 Prospectus Jun 13, 2017 —
424B4 Prospectus Jun 12, 2017 —
F-1MEF Form f-1 mef Jun 8, 2017 —
F-1/A Filing May 26, 2017 —
F-1/A Filing May 25, 2017 —
F-1/A Filing May 24, 2017 —
FWP Free writing prospectus May 22, 2017 —
F-1/A Filing May 22, 2017 —
FWP Free writing prospectus May 8, 2017 —
F-1/A Filing May 8, 2017 —
F-1/A Filing Apr 28, 2017 —
F-1/A Filing Apr 10, 2017 —
F-1/A Filing Feb 9, 2017 —
F-1 Registration statement (foreign issuer) Dec 21, 2016 —

Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMRN (Nasdaq)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Carlton, Victoria, Australia
SEC filer status
Non-accelerated filer
SEC CIK
1660046

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.